This document discusses primary glaucoma, including primary open angle glaucoma. It defines primary glaucoma as optic neuropathy with characteristic changes to the optic disc and visual field, mostly associated with increased intraocular pressure. It describes the classification, epidemiology, physiology, clinical manifestations, diagnosis and management of primary open angle glaucoma. It also discusses ocular hypertension and defines it as increased intraocular pressure without optic disc or visual field changes, noting those with high risk factors should be carefully monitored.
glaucoma of the childhood: classification , development of angle structure. pathogenesis, primary infantile glaucoma, differential diagnosis.... rest will be continued in other presentations of mine
Talk about narrow angle glaucoma in an FQHC population. Given to general medical providers in light of systemic medications that may put patients at risk for angle closure attack.
GLAUCOMA
,dignosis , types of glaucoma , risk factors oo glaucoma and treatment , the clasis of drugs that use in treatment of glaucoma.
prepared by : Hardi Sdiq
university of sullaimani
collage of pharmacy
Glaucoma: the “silent thief of sight”
Glaucoma is a leading cause of preventable sight loss. Vision can often be preserved with early identification, good adherence to treatment and long-term monitoring.
Heard of people being unable to see other people's faces if not fr failure of recognition of people's faces (prosapagnosia)...then they need to get their retina in particular macula checked! And a bunch of other macular disorders are enlisted nd elaborated in the presentation
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
5. PRIMARY GLAUCOMA: DEFINITION
OPTIC DISK CUPPING
VISUAL FIELD LOSS
OCULAR HYPERTENSION cases with constantly
IOP w/o any assoc. glaucomatous damage
NORMAL or LOW TENSION GLAUCOMA cases
with cupping of the disc and/or visual field
defects with a normal or IOP, NTG/LTG
PRIMARY OPEN-ANGLE GLAUCOMA & PRIMARY ANGLE-CLOSURE GLAUCOMA
• Refers to collection of diseases with chronic optic
neuropathy showing DISTINCTIVE CHANGES
• Mostly associated with IOP
• Normal or low-tension glaucoma also possible1
6. PRIMARY GLAUCOMA: EPIDEMIOLOGY
INCIDENCE ~60M people affected (Worldwide)
• Expected to from 64M (2015) to 76M (2020),
and 111M (2040)3
• 3M people (US) & 50% undiagnosed
RACE African Countries (highest prevalence)3
• Blacks & Whites (POAG > PCAG)
• China & Asians (PCAG – 90% of cases)
• Japan (Normal-tension glaucoma most common)
• Philippines (POAG = PCAG)4
AGE the mean IOP after 40 y/o possibly d/t
facility of aqueous outflow2
GENDER in older age
groups IOP with age
greater in females2
7. PRIMARY GLAUCOMA: PHYSIOLOGY
• Pathophysiology revolves around the
AQUEOUS HUMOUR DYNAMICS
• CILIARY BODY aqueous production
• ANGLE OF ANTERIOR CHAMBER formed by
root of iris, anterior-most part of ciliary body,
scleral spur, trabecular meshwork and
Schwalbe’s linePRINCIPAL OCULAR STRUCTURES:
10. PRIMARY GLAUCOMA: PHYSIOLOGY
• AQUEOUS OUTFLOW SYSTEM
UVEAL MESHWORK
CORNEOSCLERAL MESHWORK
JUXTACANALICULAR
(ENDOTHELIAL) MESHWORK
• TRABECULAR MESHWORK sieve-
like structure through which aqueous
humour leaves the eye
11. • SCHLEMM’S CANAL endothelial
lined oval channel to the aqueous
vein and intrascleral plexus
PRIMARY GLAUCOMA: PHYSIOLOGY
• AQUEOUS OUTFLOW SYSTEM
• COLLECTOR CHANNELS called
“Intrascleral Aqueous Vessels”, about
25-35 in number, terminate into
episcleral veins
AQUEOUS HUMOUR PRODUCTION:
• ULTRAFILTRATION
• SECRETION (ACTIVE TRANSPORT)
• DIFFUSION (PASSIVE TRANSPORT)
12. PRIMARY GLAUCOMA: PHYSIOLOGY
VACUOLATION THEORY
1 – Non-vacuolated stage
2 – Stage of early infolding of basal surface of
the endothelial cell
3 – Stage of macrovacuolar structure formation
4 – Stage of vacuolar transcellular channel
formation
5 – Stage of occlusion of the basal infolding
• “Most Accepted View” in aqueous humor flow
• Transcellular spaces exist in the endothelial
cells OPEN AS A SYSTEM OF VACUOLES
AND PORES, primarily in response to pressure
15. PRIMARY OPEN ANGLE GLAUCOMA
DEFINITION
• A type of primary glaucoma
• (–) obvious systemic or ocular cause
• IOP OPEN ANGLE of anterior chamber
• A.k.a. “CHRONIC SIMPLE GLAUCOMA OF
ADULT ONSET”
EPIDEMIOLOGY
• Varies in different populations & 1/3 of all cases of glaucoma
• RACE 4X more common & 6X more likely to cause blindness in BLACKS
• AGE 5th & 7th decades
• INCIDENCE affects ~ 1/100 of the population (of either sex) >40 y/o
16. PRIMARY OPEN ANGLE GLAUCOMA
ETIOLOGY &
PATHOPHYSIOLOGY
PREDISPOSING AND RISK FACTORS
• HEREDITY polygenic inheritance, 4%
risk in the offspring of patients
• AGE risk with age
• RACE more severe in black
• MYOPES nearsighted person
• DIABETICS higher prevalence
• SMOKING higher risk
• HIGH BLOOD PRESSURE
• THYROTOXICOSIS does not cause
IOP, but prevalence more in Graves’
ophthalmic patients than the normals IOP
AQUEOUS OUTFLOW
FACILITY
RESISTANCE TO
AQUEOUS OUTFLOW
TRABECULAR MESHWORK
THICKENING & SCLEROSIS
ABSENCE OF GIANT
VACUOLES (CANAL
OF SCHLEMM)
CAUSE UNCERTAIN
UNCONTROLLED
17. PRIMARY OPEN ANGLE GLAUCOMA
VISUAL FIELD
DEFECTS
FORCES THE LAMINA
CRIBROSA BACKWARDS
MECHANICAL EFFECTS
VASCULAR EFFECTS
DAMAGING CASCADE
ISCHAEMIC
ATROPHY
SQUEEZES THE
NERVE FIBRES
VISUAL FIELD LOSS
DEATH OF RETINAL
GANGLION CELLS (RGC’s)
LARGE CAVERNS OR LACUNAE ARE
FORMED (CAVERNOUS OPTIC ATROPHY)
18. PRIMARY OPEN ANGLE GLAUCOMA
CLINICAL MANIFESTATIONS
SYMPTOMS
• Insidious & usually ASYMPTOMATIC
• Mild headache & eyeache
• Frequent changes in presbyopic
glasses
• Delayed dark adaptation
SIGNS
• ANTERIOR SEGMENT SIGNS
pupil reflex becomes sluggish &
cornea may show slight haze (LATE
STAGES)
SIGNS
• IOP CHANGES IOP falls during
the evening (most patients) in Diurnal
Variation Test
19. PRIMARY OPEN ANGLE GLAUCOMA
SIGNS
• OPTIC DISC CHANGES seen on
fundoscopic exam
• VERTICALLY OVAL CUP d/t
selective loss of neural rim tissue in
the inferior and superior poles
• ASYMMETRY OF THE CUPS
difference of > 0.2 b/w two eyes
OPTIC DISK CUPPING
1. EARLY GLAUCOMATOUS CHANGES
Reveals one or more of the following
signs:
NORMAL
20. PRIMARY OPEN ANGLE GLAUCOMA
• LARGE CUP 0.6 or more
(Normal cup size – 0.3 to 0.4) may
occur d/t concentric expansion
• SPLINTER HAEMORRHAGES
present on/near optic disc margin
• PALLOR AREAS present on disc
• ATROPHY OF RETINAL NERVE FIBRE
LAYER seen with red free light
1. EARLY GLAUCOMATOUS CHANGES
Reveals one or more of the following
signs:
NORMAL EARLY CHANGE
21. PRIMARY OPEN ANGLE GLAUCOMA
• MARKED CUPPING cup size 0.7
to 0.9, excavation may even reach
the disc margin
• THINNING OF NEURORETINAL RIM
seen as a crescentric shadow
adjacent to the disc margin
• NASAL SHIFTING OF RETINAL
VESSELS appearance of being
broken off at the margin –
BAYONETTING SIGN
2. ADVANCED GLAUCOMATOUS CHANGES
Reveals one or more of the following signs:
NORMAL LATE CHANGE
22. PRIMARY OPEN ANGLE GLAUCOMA
• PULSATIONS OF THE RETINAL
ARTERIOLES may be seen at the
disc margin (a PATHOGNOMIC
SIGN of glaucoma), when IOP is
very high
• LAMELLAR DOT SIGN pores in
the lamina cribrosa are slit-shaped
and are visible up to the margin of
the disc
2. ADVANCED GLAUCOMATOUS CHANGES
Reveals one or more of the following signs:
NORMAL LATE CHANGE
23. PRIMARY OPEN ANGLE GLAUCOMA
• As the damage progresses, all the
NEURAL TISSUE of the disc is
destroyed and the OPTIC NERVE
HEAD appears white & excavated
3. GLAUCOMATOUS OPTIC ATROPHY
Reveals one or more of the following signs:
NORMAL OPTIC ATROPHY
24. PRIMARY OPEN ANGLE GLAUCOMA
• VISUAL FIELD DEFECTS usually run
parallel to the changes at optic nerve
head & progresses if IOP is not controlled
• SRF & IRF superior and inferior
radiating fibres from nasal half
• PMB PAPILLOMACULAR BUNDLE
from macular area
• SAF & IAF superior & inferior
arcuate fibres from the temporal half
ANATOMICAL BASIS OF FIELD DEFECTS
• DISTRIBUTION OF RETINAL NERVE FIBRES
25. PRIMARY OPEN ANGLE GLAUCOMA
• VISUAL FIELD DEFECTS usually run
parallel to the changes at optic nerve
head & progresses if IOP is not controlled
• From peripheral part – lie deep in the
retina but occupy the most peripheral
(superficial) part of the optic disc
• Fibres originating closer to the nerve
head – lie superficially and occupy a
more central (deep) portion of the disc.
EARLY LOSS IN THE VISUAL FIELD REGIONS
RETENTION OF CENTRAL VISION TILL END
ANATOMICAL BASIS OF FIELD DEFECTS
• ARRANGEMENT OF NERVE FIBRES WITHIN
OPTIC NERVE HEAD
• ARCUATE FIBERS (SAF & IAF) occupy the
superior & inferior temporal half of optic
nerve head – most sensitive to damage
• MACULAR FIBRES most resistant to the
glaucomatous damage
26. PRIMARY OPEN ANGLE GLAUCOMA
• VISUAL FIELD DEFECTS usually run
parallel to the changes at optic nerve
head & progresses if IOP is not controlled
PROGRESSION OF FIELD DEFECTS
• ISOPTER CONTRACTION mild
generalized constriction of central as
well as peripheral field
EARLIEST
VISUAL FIELD
DEFECT
• BARING OF BLIND SPOT exclusion
of the blind spot from the central
field d/t inward curve of the outer
boundary of 30° central field
• SMALL WING-SHAPED PARACENTRAL
SCOTOMA appear below or above
the blind spot in BJERRUM'S AREA
EARLIEST
CLINICALLY
SIGNIFICANT
FIELD DEFECT
• SEIDEL’S SCOTOMA “Sickle-shaped”
in time, paracental scotoma joins the
blind spot
27. PRIMARY OPEN ANGLE GLAUCOMA
• ARCUATE OR BJERRUM’S SCOTOMA
formed by extension of Seidel’s scotoma
in an area either above or below the
fixation point to reach the horizontal line
• RING / DOUBLE ARCUATE SCOTOMA
develops when the two arcuate
scotomas join together
• ROENNE'S CENTRAL NASAL STEP two
arcuate scotomas run in different arcs and
meet to form a sharp right-angled defect
at the horizontal meridian
• PERIPHERAL FIELD DEFECTS
can appear in early and
late stages
• ADVANCED FIELD DEFECTS
eventually only a small
island of central vision
(TUBULAR VISION) are left
29. PRIMARY OPEN ANGLE GLAUCOMA
DIAGNOSTIC FACTORS
• CRITERIA to diagnose EARLY, MODERATE and SEVERE glaucomatous field defects
30. PRIMARY OPEN ANGLE GLAUCOMA
• TONOMETRY measures the IOP
TWO BASIC TYPES OF TONOMETERS:
INDENTATION (IMPRESSION)
2. Schiotz Tonometer
APPLANATION
1. Goldmann
Tonometer
31. PRIMARY OPEN ANGLE GLAUCOMA
• DIURNAL VARIATION TEST
useful in detection of early cases
A – Normal slight morning rise
B – Morning rise seen in 20% cases
C – Afternoon rise seen in 25%
D – Biphasic variation seen in 55%
• SLIT-LAMP EXAMINATION to R/O
causes of 2° Open Angle Glaucoma
• WATER DRINKING TEST eyes with
glaucoma with greater response to
water drinking
a. 8 hours fasting, then baseline IOP
b. Patient drinks 1L of water, then IOP noted
q 15min for 1 hour
c. Rise of 8 mmHg or more (DIAGNOSTIC)
• NERVE FIBRE LAYER ANALYZER to
detect damage in retinal nerve fibres
32. PRIMARY OPEN ANGLE GLAUCOMA
• PERIMETRY detect visual field defects
TWO CLASSIFICATIONS OF PERIMETERS:
GOLDMANN’S PERIMETER
1. Manual PerimeterLISTER’S PERIMETER
2. Automated Perimeter
HUMPHREY FIELD ANALYSER
• ADVANTAGES OF AUTOMATED:
1. Level of precision & consistency
2. data storage capability & ease
3. Statistical comparison
33. PRIMARY OPEN ANGLE GLAUCOMA
• GONIOSCOPY primary importance in POAG is
to rule out other forms of glaucoma
GOLDMANN’S GONIOLENS & TECHNIQUE OF GONIOSCOPY
• APPLICATIONS OF GONIOSCOPY:
1. Classification of glaucoma into open angle and
closed angle based on configuration of the angle
2. Localization of foreign bodies, abnormal blood
vessels or tumors in the angle.
3. Demonstration of extent of peripheral anterior
synechiae and hence planning of glaucoma surgery
4. Direct goniolens is used during goniotomy
34. PRIMARY OPEN ANGLE GLAUCOMA
SHAFFER’S
SYSTEM OF
GRADING THE
ANGLE WIDTH
MOST COMMONLY USED
36. OCULAR HYPERTENSION
DEFINITION
• “Glaucoma Suspect”
• IOP constantly >21mmHg but NO OPTIC
DISC or VISUAL FIELD CHANGES
ETIOLOGIC FACTORS
HIGH RISK FACTORS
• IOP CONSTANTLY >28 mmHg
• SIGNIFICANT DIURNAL VARIATION difference
of > 8mmHg
• Significantly positive WATER DRINKING TEST
• Association with SPLINTER HEMORRHAGES
• RETINAL NERVE FIBER LARGE DEFECTS
• PARAPAPILLARY CHANGES
• CENTRAL CORNEAL THICKNESS < 555 μm
Should be CAREFULLY MONITORED
by an ophthalmologist, should be
treated as cases of POAG in the
presence of HIGH RISK FACTORS
37. OCULAR HYPERTENSION
OTHER RISK FACTORS
• SIGNIFICANT ASYMMETRY in the cup size of
the two eyes difference of more than 0.2
• Strong FAMILY HISTORY of glaucoma
• When associated with HIGH MYOPIA,
DIABETES or PIGMENTARY CHANGES in the
anterior chamber
MANAGEMENT
• WITH HIGH RISK FACTORS treated on
the lines of POAG (aim is to reduce IOP by
20%)
• NO HIGH RISK FACTORS annually
followed by examination of optic disc,
perimetry and record of IOP, treatment not
required till glaucomatous damage is
documented
39. NORMAL TENSION GLAUCOMA
DEFINITION
• (NTG), A.k.a LOW TENSION GLAUCOMA,
typical glaucomatous DISC CHANGES, but
WITH / WITHOUT VISUAL FIELD DEFECTS
• Associated with IOP constantly <21 mmHg
EPIDEMIOLOGY
• Variant of POAG (16% of all
cases of POAG)
• AGE prevalence >40 y/o is
0.2%
ETIOLOGY & PATHOPHYSIOLOGY
OPTIC NERVE
SUSCEPTIBLE
CHRONIC LOW
VASCULAR
PERFUSION
PREDISPOSING AND RISK FACTORS
• Raynauld phenomenon
• Migraine
• Nocturnal systemic hypotension
• Overtreated systemic hypertension
• blood flow velocity (ophthalmic artery)
VASCULAR EFFECT ONLY!
40. NORMAL TENSION GLAUCOMA
CLINICAL MANIFESTATIONS
• Disc changes & visual field defects
(Similar to POAG)
• NORMAL IOP
• Other features of NTG are some
ASSOCIATIONS mentioned
DIFFERENTIAL DIAGNOSIS
• POAG early stages POAG may
present with normal IOP
• Congenital optic disc anomalies
• APPROXIMATELY 60% HAVE
PROGRESSIVE VISUAL FIELD LOSS
41. NORMAL TENSION GLAUCOMA
MANAGEMENT
• MEDICAL TREATMENT to IOP IOP
by 30% (about 12-14 mmHg)
a. BETAXOLOL DOC d/t in addition to
IOP, also optic nerve blood flow
b. Other Beta Blockers and Adrenergic
drugs (DIPIVERAFRINE) be avoided
(causes nocturnal systemic hypotension
& are likely to affect adversely the
optic nerve perfusion)
c. NEUROPROTECTIVE DRUGS may
be preferred like “Brimonidine”
d. PROSTAGLANDIN ANALOGUES
greater ocular hypotensive effect
• TRABECULECTOMY considered
when progressive field loss occurs
despite IOP in lower teens
• SYSTEMIC Ca2+ BLOCKERS for
confirmed peripheral vasospasm
• SYSTEMIC BP MONITORING
43. PRIMARY ANGLE-CLOSURE GLAUCOMA
DEFINITION
• A type of primary glaucoma, (–) obvious
systemic or ocular cause
• IOP occurs d/t BLOCKAGE of the
aqueous humour outflow
• Closure of a NARROWER ANGLE of the
anterior chamber
EPIDEMIOLOGY
• AGE more common in 5th decade of life
• GENDER F>M (Ratio 4:1)
• RACE South-East Asian, Chinese (50% of
all primary glaucoma) or Inuit/ Eskimos2
• SEASON higher in rainy season
• FAMILY HISTORY inherited
• TYPE OF PERSONALITY common in
individuals with unstable vasomotors
44. PRIMARY ANGLE-CLOSURE GLAUCOMA
ETIOLOGY & PATHOPHYSIOLOGY
I. ANATOMICAL FACTORS
• HYPERMETROPIA with shallow
anterior chamber
• Iris-lens DIAPHRAGM placed
anteriorly
• NARROW ANGLE of anterior
chamber, which may be d/t:
a. Small eyeball
b. Relatively large size of the
lens & smaller diameter of
the cornea
c. Bigger size of the ciliary
body
II. GENERAL
FACTORS
• AGE
• GENDER
• RACESEASON
• FAMILY HISTORY
• TYPE OF PERSO-
NALITY
PREDISPOSING
RISK FACTORS
The following factors may
PRECIPITATE an attack:
• DIM ILLUMINATION
• EMOTIONAL STRESS
• MYDRIATIC DRUGS like
Atropine, Tropicamide
PRECIPITATING
FACTORS INCREASED
AMOUNT OF
APPOSITION B/W
IRIS
ANTERIORLY
PLACED LENS WITH
CONSIDERABLE
PRESSURE
NORMAL PUPIL
MILD PUPIL
DILATATION
45. PRIMARY ANGLE-CLOSURE GLAUCOMA
RELATIVE
PUPIL
BLOCK
AQUEOUS HUMOR COLLECTS IN THE POSTERIOR CHAMBER
PUSHES THE PERIPHERAL FLACCID IRIS ANTERIORLY
IRIS
BOMBE
APPOSITIONAL
ANGLE CLOSURE
SYNECHIAL
ANGLE CLOSURE
ATTACK OF IOP
MAY LAST LONGER
ACUTE PACG
CHRONIC PACG
Results from the following
CIRCUMSTANCES:
• CREEPING SYNECHIAE
• SUBACUTE PACG ATTACKS
• MIXED MECHANISM
46. PRIMARY ANGLE-CLOSURE GLAUCOMA
CLINICAL MANIFESTATIONS:
LATENT PRIMARY ANGLE-CLOSURE
GLAUCOMA “Glaucoma suspect”
SUBACUTE OR INTERMITTENT PACG
ACUTE ANGLE-CLOSURE GLAUCOMA
POSTCONGESTIVE
ANGLE-CLOSURE GLAUCOMA
CHRONIC PACG
FIVE DIFFERENT CLINICAL ENTITIES
47. PRIMARY ANGLE-CLOSURE GLAUCOMA
CLINICAL MANIFESTATIONS:
LATENT PRIMARY ANGLE-CLOSURE
GLAUCOMA “Glaucoma suspect”
INDICATES DECREASED AXIAL ANTERIOR
CHAMBER DEPTH
• Eyes with shallow anterior chamber
with an OCCLUDABLE ANGLE
• SYMPTOMS absent
• ECLIPSE SIGN elicited by shining a
penlight across the anterior chamber
from temporal side, noting a shadow
on the nasal side
FIVE DIFFERENT CLINICAL ENTITIES
48. PRIMARY ANGLE-CLOSURE GLAUCOMA
CLINICAL MANIFESTATIONS:
• GONIOSCOPIC EXAMINATION it
shows very narrow angle (SHAFFER
GRADE 1)
• SLIT-LAMP BIOMICROSCOPIC SIGNS:
a.axial anterior chamber depth
b.Convex shaped iris lens diaphragm
c. Close proximity of the iris to cornea
in the periphery
LATENT PRIMARY ANGLE-CLOSURE
GLAUCOMA “Glaucoma suspect”
FIVE DIFFERENT CLINICAL ENTITIES
49. PRIMARY ANGLE-CLOSURE GLAUCOMA
CLINICAL MANIFESTATIONS:
LATENT PRIMARY ANGLE-CLOSURE
GLAUCOMA “Glaucoma suspect”
• VAN HERICK SLIT-LAMP GRADING
used when gonioscope is not available
(FAIR ACCURACY)
• Peripheral Anterior Chamber Depth
(PACD) compared to the adjacent
corneal thickness (CT) and the
presumed angle width
• CLINICAL COURSE if without Tx,
may follow any of the following:
a. IOP may remain NORMAL
b. SUBACUTE or ACUTE angle-closure
glaucoma may occur subsequently
c. CHRONIC angle-closure glaucoma
may develop without passing
through subacute or acute stage
FIVE DIFFERENT CLINICAL ENTITIES
50. PRIMARY ANGLE-CLOSURE GLAUCOMA
VAN HERICK METHOD OF
SLIT-LAMP GRADING
A – Grade IV
B – Grade III
C – Grade II
D – Grade I
E – Grade 0
GRADES:
Grade 4 (WIDE OPEN ANGLE)
• PACD = 3/4 to 1 CT
Grade 3 (MILD NARROW)
• PACD = ¼ to ½ CT
Grade 2 (MODERATE NARROW)
• PACD = ¼ CT
Grade 1 (EXTREMELY NARROW)
• PACD < ¼ CT
Grade 0 (CLOSED ANGLE)
• PACD Nil
51. PRIMARY ANGLE-CLOSURE GLAUCOMA
CLINICAL MANIFESTATIONS:
FIVE DIFFERENT CLINICAL ENTITIES
• Attack of TRANSIENT IOP (40-50
mmHg) (last for minutes to 1-2 hours)
• Usually PRECIPITATED by:
a. PHYSIOLOGICAL MYDRIASIS
reading in dim light, watching TV or
cinema in darkened room, or during
anxiety (Sympathetic Overactivity)
b. PHYSIOLOGICAL SHALLOWING
OF ANTERIOR CHAMBER after
lying in prone position
SUBACUTE OR INTERMITTENT PACG
• SYMPTOMS unilateral transient
blurring of vision, coloured halos
around light, headache, browache
and eyeache on the affected side
COLOURED HALOS AROUND LIGHT
52. PRIMARY ANGLE-CLOSURE GLAUCOMA
CLINICAL MANIFESTATIONS:
FIVE DIFFERENT CLINICAL ENTITIES
• During PE, eye is white & not congested
• All the signs described in LATENT PACG
can be elicited in this phase ALSO
• CLINICAL COURSE if without Tx,
may follow any of the following:
a. Attack of ACUTE PACG
b. CHRONIC PACG without passing
through acute stage
SUBACUTE OR INTERMITTENT PACG
53. PRIMARY ANGLE-CLOSURE GLAUCOMA
CLINICAL MANIFESTATIONS:
FIVE DIFFERENT CLINICAL ENTITIES
• Attack of Acute PACG occurs d/t a
sudden total angle closure leading to
SEVERE RISE in IOP
ACUTE ANGLE-CLOSURE GLAUCOMA
SIGHT THREATENING EMERGENCY!
SYMPTOMS
• PAIN sudden onset of very severe pain
that radiates along the CN-V branches
• NAUSEA, VOMITING, PROSTRATIONS
• Rapid progress of VISION LOSS also
with redness, photophobia & lacrimation
(PRESENT IN ALL CASES)
• PAST HISTORY ~5% (+)Hx of typical
previous transient attacks of subacute
angle-closure glaucoma
54. SIGNS
• LIDS may be edematous
• CONJUNCTIVA congested
• CORNEA edematous & insensitive
• ANTERIOR CHAMBER very shallow
• ANGLE OF ANTERIOR CHAMBER
closed completely (SHAFFER GRADE0)
• IRIS may be discoloured
PRIMARY ANGLE-CLOSURE GLAUCOMA
CLINICAL MANIFESTATIONS:
FIVE DIFFERENT CLINICAL ENTITIES
ACUTE ANGLE-CLOSURE GLAUCOMA
•NOTE CILIARY CONGESTION,
•CORNEAL EDEMA & MIDDILATED PUPIL
DISCOLOURED IRIS
VERY SHALLOW –
ANTERIOR CHAMBER
55. SIGNS
• IOP it is usually markedly elevated,
b/w 40-70 mmHg (NV:10-21mmHg)
• PUPIL semi-dilated, vertically oval
and fixed, usually non-reactive to both
light & accommodation
• OPTIC DISC edematous, hyperemic
• FELLOW EYE shows shallow anterior
chamber and a narrow angle
PRIMARY ANGLE-CLOSURE GLAUCOMA
CLINICAL MANIFESTATIONS:
FIVE DIFFERENT CLINICAL ENTITIES
ACUTE ANGLE-CLOSURE GLAUCOMA
PUPIL NON-REACTIVE TO BOTH LIGHT & ACCOMMODATION
EDEMATOUS & HYPEREMIC OPTIC DISC
56. PRIMARY ANGLE-CLOSURE GLAUCOMA
CLINICAL MANIFESTATIONS:
FIVE DIFFERENT CLINICAL ENTITIES
POSTCONGESTIVE
ANGLE-CLOSURE GLAUCOMA
• VOGT’S TRIAD seen with any type
of post-congesive glaucoma & in
treated acute congestive glaucoma:
a. GLAUCOMFLECKEN an anterior
sub-capsular lenticular opacity
b. PATCHES OF IRIS ATROPHY
c. SLIGHTLY DILATED NON-REACTING
PUPIL due to sphincter atrophy PATCHES OF IRIS ATROPHY
SLIGHTLY DILATED NON-
REACTING PUPIL
GLAUCOMFLECKEN
VOGT’S TRIAD
57. PRIMARY ANGLE-CLOSURE GLAUCOMA
CLINICAL MANIFESTATIONS:
FIVE DIFFERENT CLINICAL ENTITIES
POSTCONGESTIVE
ANGLE-CLOSURE GLAUCOMA
1.POSTSURGICAL POSTCONGESTIVE
PACG after laser peripheral
iridotomy (PI) treatment for an
attack of acute PACG
FOUR CLINICAL SETTINGS
• Clinical status of eye after an attack of
acute PACG with or without treatment
• With normalized IOP post-laser Tx,
the eye usually “QUITENS” after some
time with/without s/s of acute attack
• With raised IOP after unsuccessful Tx,
there occurs a STATE OF CHRONIC
CONGESTIVE GLAUCOMA
58. PRIMARY ANGLE-CLOSURE GLAUCOMA
CLINICAL MANIFESTATIONS:
FIVE DIFFERENT CLINICAL ENTITIES
POSTCONGESTIVE
ANGLE-CLOSURE GLAUCOMA
2.SPONTANEOUS ANGLE OPENING
may very rarely occur in some cases
and the attack of acute PACG may
subside itself without treatment
FOUR CLINICAL SETTINGS
• Clinical status of eye after an attack of
acute PACG with or without treatment
3. CHRONIC CONGESTIVE PACG
continuation of acute congestive angle-
closure glaucoma when no Tx or when is
unsuccessful
a. EYE permanently congested, pain
reduced d/t “ACCLAMATIZATION”
b. IOP remains constantly raised
c. LID & CONJUCTIVAL EDEMA
d. OPTIC DISC may show cupping
e. Other features are similar to acute
congestive angle-closure glaucoma
4. CILIARY BODY SHUT DOWN
temporary cessation of aqueous humor
secretion due to ischemic damage
a. IOP is low, PAIN is “MARKEDLY”
59. • Similar to POAG, EXCEPT that the
angle in Chronic PACG is narrow
• IOP constantly raised
• EYEBALL it is usually remains white
(without congestion) & PAINLESS
• OPTIC DISC may show cupping
• VISUAL FIELD DEFECTS like POAG
• GONIOSCOPY variable degree of
angle closure
PRIMARY ANGLE-CLOSURE GLAUCOMA
CLINICAL MANIFESTATIONS:
FIVE DIFFERENT CLINICAL ENTITIES
CHRONIC PACG
PAINLESS EYEBALL
60. PRIMARY ANGLE-CLOSURE GLAUCOMA
ABSOLUTE PACG if no Tx for chronic
phase, with/without sub-acute attacks,
gradually passes into “FINAL PHASE”
a. PAINFUL BLIND EYE irritability & now
completely blind (NO LIGHT PERCEPTION)
b. PERILIMBAL REDDISH BLUE ZONE slight
ciliary flush around the cornea d/t dilated
anterior veins
c. CORNEA clear but insensitive
d. ANTERIOR CHAMBER very shallow
e. IRIS becomes atrophic
f. PUPIL fixed, dilated, greenish hue
g. OPTIC DISC shows atrophy
h. INTRAOCULAR PRESSURE high
i. EYEBALL becomes stony hard
PERILIMBAL REDDISH BLUE ZONE
PAINFUL BLIND EYE
INSENSITIVE
CORNEA
61. PRIMARY ANGLE-CLOSURE GLAUCOMA
DIAGNOSTIC FACTORS:
CLINICAL ENTITY DIAGNOSIS
LATENT PRIMARY ANGLE-
CLOSURE GLAUCOMA
DIAGNOSIS MADE BY:
• CLINICAL SIGNS described beforehand
• PROVOCATIVE TESTS designed to precipitate closure of
the angle in the ophthalmologist’s office, where it can be
treated promptly
a. PRONE-DARKROOM TEST it is the most popular & best
physiological provocative test for PACG
b. MYDRIATIC PROVOCATIVE TEST not preferred now
SUBACUTE PRIMARY ANGLE-
CLOSURE GLAUCOMA
ACUTE, POSTCONGESTIVE,
CHRONIC, ABSOLUTE PACG
*DIAGNOSIS USUALLY OBVIOUS FROM THE CLINICAL SIGNS1